Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants

  1. Bove, R.
  2. Hellwig, K.
  3. Pasquarelli, N.
  4. Borriello, F.
  5. Dobson, R.
  6. Oreja-Guevara, C.
  7. Lin, C.-J.
  8. Zecevic, D.
  9. Craveiro, L.
  10. McElrath, T.
  11. Vukusic, S.
Zeitschrift:
Multiple Sclerosis and Related Disorders

ISSN: 2211-0356,  2211-0348

Datum der Publikation: 2022

Ausgabe: 64

Art: Artikel

DOI: 10.1016/J.MSARD.2022.103963 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus